A study of a new drug in healthy adults
Part of Infections, Skin clinical trials.
This study tests a new drug called CMS-F021 in healthy volunteers. It aims to see how the drug behaves in the body after single and multiple doses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be between 19 and 26.
- You must not have any active skin infections or a history of severe skin problems.
- You must not have taken any medications (including over-the-counter drugs, vitamins, or herbal supplements) within the last 2 weeks.
- You must not have donated blood or lost more than 400 mL of blood in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gives healthy volunteers a small, safe dose of a radiolabeled (radioactive) drug to see how it is absorbed, broken down, and removed from the body. By participating, you help researchers understand the drug's behavior, which informs future dosing and safety.
This trial tests a new investigational drug called CMS-D017 in healthy volunteers. Researchers will give single and multiple doses to see how the body processes it and if it's safe. You could help find an important new treatment.
This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This study tests an experimental antibiotic called BWC0977 to see if it is safe and well-tolerated when given as single and multiple doses. It is for healthy volunteers to understand how the drug behaves in the body before moving to patient trials.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.